- Renowned oncologists from India and International medical fraternity explore ‘New Horizons in Cancer Care’
- Marking their presence at the event were International experts Dr Robert Gallo, co-discoverer of HIV and winner of prestigious US Lasker award & Dr Neal Flomenberg, pioneer in bone marrow transplant
- The event encouraged discussions on innovation and a panel discussion on drawing attention to the need of a cancer registry in India
Kochi, November 9, 2014: Aimed at exploring newer horizons and improving cancer management and care in India, Aster Medcity, one of India’s most advanced quaternary care medical centre was host to a major international cancer conclave titled ‘New Horizons in Cancer Care’. The event held on November 09, witnessed participation from 150 eminent national and international medical personalities.
Experts present at the event, deliberated on harnessing multi-disciplinary treatment resources, economics of treating cancer, need for a population based cancer registry for India and most importantly the role of media and the public in creating awareness on early detection and possible prevention. The event was graced by the presence of Dr Azad Moopen, Chairman, Aster DM Healthcare.
“Every year nearly one million new cancer cases are diagnosed in India according to reports. The number of deaths per year due to cancer is expected to rise to 1.2 million every year by 2035. This conclave provides a platform to bring in latest developments and technological innovation regarding cancer care. Through Aster Medcity, we will enable best-in-class treatment for cancer patients” said Dr Azad Moopen.
Sharing his experience on cancer research was Dr Robert Gallo. Two times winner of the prestigious US Lasker award and co-discoverer of HIV, Dr Robert Gallo addressed the session on viruses and cancers. Dr Neal Flomenberg, pioneer of bone marrow transplant and popularly known for his ground-breaking research in bone marrow transplantation, elaborated on the advances in the field and share his experience of contemporary technology and treatments available for cancer management.
A one day conclave spearheaded by Dr MV Pillai and Dr Harish Pillai, CEO, Aster Medcity brought together the best minds in the field of oncology. The thrust of the event was upon greater innovations and medical excellences in cancer treatment.
Speaking about the conclave, Dr. Harish Pillai, CEO - Aster Medcity, said “Cancer is a disease that most people have heard, however, awareness in terms of its treatment and prevention is relatively low. Through this conclave want to draw attention towards need of a cancer registry in India which will help track the incidents and treatment developments. As a further step in our efforts to fight cancer in India, we will soon announce the opening of Aster Medcity Oncology Centre of Excellence which we are certain will be the best in class centre for cancer care.”
Commenting on the newer heights of achieving cancer care in India, Dr. M V Pillai, Senior Medical Oncologist at Thomas Jefferson University, Philadelphia US said, “It gives me immense pleasure to spearhead this conclave and address the expert oncologists present at the conclave. While India has largely evolved in stepping up cancer treatment, there is still lot to consider in terms of its awareness and prevention among general public.”
